Ledger. Australian venture funding, tracked

Founder, Ankere Therapeutics

Associate Professor Bernard Flynn

Coverage

Stories naming Associate Professor Bernard Flynn. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Seed $10m

Australian collaboration and AU$10m investment fuels Ankere Therapeutics’ efforts to target inflammatory lung conditions

Biotech startup Ankere Therapeutics launches with a $10 million seed round co-led by IP Group and Brandon Capital to develop inflammatory lung disease therapies, building on research from Monash and UniSA scientists.

Brandon BioCatalyst portfolio 3 May 2022 Ankere TherapeuticsAkeyulerreBrandon BioCatalystCannings Strategic CommunicationsCentre for Cancer BiologyGo8 UniversitiesMana CommunicationsMonash Institute of Pharmaceutical SciencesMonash UniversitySA PathologyUniversity of South AustraliaBrandon CapitalIP Group AustraliaAileen BodartAssociate Professor Bernard FlynnBernard FlynnCiara ByrneDr Melissa McBurnieDr Siro PerezStuart Pitson

Also Brandon Capital portfolio·Startup Daily·@AuManufacturing

Something wrong? Tell us